查看其它语言版本

Bioprospect Limited

ASX:MEB ISIN:AU000000MEB8

 BioProspect Limited operates in the biotechnology industry focusing on natural plant extracts for use within the insecticide, termiticide and human health markets. The Company operates within Australia region, has patents for Termilone lodged in Japan, United States and Australia. On August 22, 2007, the Company signed an agreement with Solagran Limited to develop and commercialize a range of Bioeffectives in the animal health, nutrition and agricultural markets on an international scale.

  

新闻

7月29日澳洲股市:美国消费者信心下降

🕔7/29/2009 11:07:26 AM 11113

在一份调查结果显示消费者信心弱于预期之后,昨晚美国股市平淡收市。美国经济咨商局(Conference Board)报告称,信心指数从6月份的49.3下降到了46.6,主要原因是就业市场恶化。

阅读全文
###

44,824 公司背景浏览

  • 本页浏览人次: (过去7日: 15) (过去30日: 64) (自发布以来: 7399) 

公司详细信息

社会化媒体